Answers are grounded in this paper and cite their sources.
Women with breast cancer and a BRCA1 or BRCA2 mutation face high risks of contralateral breast cancer, and many opt for bilateral mastectomy. We used a simulation approach to predict the benefit of risk-reducing mastectomy (RRM) on 20-year survival.
No takes yet. Share an insight, caveat, or question.
Giannakeas et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: